MAX
Actuate Therapeutics, Inc. Common stock
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
-2.49 | -1333.21 | -99.81% | -2.44 | +2.01% |
| P/S |
|
0 | 32.06 | -100% |
|
|
| P/BV |
|
639.69 | -179.78 | -455.82% |
|
|
| P/FCF |
|
-3.11 | -1263.3 | -99.75% |
|
|
| Ev/Ebitda |
|
-2.31 | -1765.19 | -99.87% |
|
|
| Ev/S |
|
0 | 8.13 | -100% |
|
|
| Ev/FCF |
|
-2.66 | -1286.26 | -99.79% |
|
|
| E/P |
|
-0.4 | -0.0025 | 16224.86% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
0 | 5.63 | -100% | 0 | 0% |
| ROE |
|
54.83 | 171.81 | -68.08% |
|
|
| ROA |
|
-443.16 | -43.74 | 913.17% |
|
|
| ROIC |
|
0 | 0 | 0% |
|
|
| ROS |
|
0 | 5.16 | -100% |
|
|
| ROCE |
|
-26207.02 | -15.8 | 165727.54% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
0 | 0.0198 | -100% | -0.0121 | -100% |
| Nеt Debt/Ebitda |
|
0.34 | -0.27 | -227.29% |
|
|
| Debt/Ratio |
|
0 | 0.0738 | -100% |
|
|
| Debt/Equity |
|
88.44 | -0.79 | -11241.4% |
|
|
| Debt/Net Income |
|
0 | -0.0578 | -100% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0 | 0% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0 | 0% | ||
| DSI |
|
0 | 0 | 0% |
|
|
| Average dividend growth |
|
0 | 0 | 0% |
|
|
| Average percentage for 5 years |
|
0 | 0 | 0% |
|
|
| Average percentage for payments |
|
0 | 0 | 0% |
|
|
| Difference from average difference in sector |
|
0 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
0 | 294.53 | -100% | ||
| Growth impulse Ebitda in 5 years |
|
24.91 | 492.37 | -94.94% | ||
| Growth impulse Net Income in 5 years |
|
35.35 | 146.17 | -75.82% | ||
| Growth impulse FCF in 5 years |
|
22.75 | -77.7 | -129.28% | ||
| Growth impulse EPS in 5 years |
|
32.55 | -177.03 | -118.39% |
IP Score
3.18/10
